BLUE Company Profile and Key Details

Q: Who are the executives of BLUE?

Sarah AlspachChief Communications OfficerDr. Liviu Niculescu M.D., Ph.D.Senior Vice President of Global Medical AffairsMr. Richard Colvin M.D., Ph.D.Chief Medical OfficerMr. Christopher Krawtschuk CPAChief Financial Officer, Principal Accounting Officer & TreasurerMr. Thomas J. KlimaChief Commercial Officer & Chief Operating OfficerMs. Elizabeth PingpankDirector of Corporation CommunicationsMr. Scott ShoemakerSenior Vice President of QualityMs. Melissa BonnerSenior Vice President of ResearchJess RowlandsHead of Corporation CommunicationsMr. Christopher Krawtschuk C.P.A.Chief Financial Officer, Principal Accounting Officer & TreasurerMs. Andrea WaltonChief People OfficerMr. Andrew ObenshainPres, Chief Executive Officer & DirectorMr. Richard A. Colvin M.D., Ph.D.Chief Medical OfficerMr. Kasra KasraianSenior Vice President of Technical Devel. & OperationsMr. Joseph D. Vittiglio Esq., J.D.Chief Bus. & Legal Officer and Corporation Sec.

NASDAQ : BLUE

bluebird bio

$4.97

At Close 4:00 PM

Not Actively Trading

62.53

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

bluebird bio, Inc. (BLUE) stock remained unchanged at $4.97 a share on NASDAQ. The stock opened at $4.97, fluctuating between $4.97 to $4.97 during the session.

Stock Snapshot

4.97

Prev. Close

48.67M

Market Cap

4.97

Day Low

-0.2413793103448276

P/E Ratio

-20.59

EPS (TTM)

-2.63

Cash Flow per Share

4.97

Open

9.79M

Number of Shares

4.97

Day High

99.32%

Free Float in %

2.04

Book Value

1.25M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 30, 2025	4.74	5.03	4.67	4.97	1.23M
May 29, 2025	4.65	4.98	4.40	4.97	693.94K
May 28, 2025	4.99	5.00	4.98	4.98	878.93K
May 27, 2025	4.99	5.01	4.98	5.00	941.8K
May 23, 2025	4.99	4.99	4.98	4.99	217.21K
May 22, 2025	4.98	4.99	4.98	4.99	225.04K
May 21, 2025	4.97	4.99	4.97	4.97	781.6K
May 20, 2025	4.98	4.99	4.97	4.98	482.68K
May 19, 2025	4.97	4.99	4.97	4.98	612.76K
May 16, 2025	4.97	4.99	4.97	4.97	560.54K
May 15, 2025	4.98	4.99	4.97	4.97	704.68K
May 14, 2025	4.97	4.99	4.95	4.98	9.34M
May 13, 2025	3.33	3.34	3.20	3.31	277.27K
May 12, 2025	3.55	3.56	3.28	3.29	2.88M
May 09, 2025	3.73	3.78	3.48	3.50	417.8K
May 08, 2025	3.69	3.82	3.68	3.71	120.65K
May 07, 2025	3.82	3.86	3.62	3.69	134.82K
May 06, 2025	3.93	3.93	3.78	3.84	131.88K
May 05, 2025	3.91	4.00	3.81	3.97	185.19K
May 02, 2025	4.07	4.13	3.91	3.95	104.17K

Contact Details

Cambridge, MA 02142

United States

https://www.bluebirdbio.com 339 499 9300

About Company

bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent �-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clinical study program includes HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with �-thalassemia. It has strategic collaboration and license agreements with Orchard Therapeutics Limited, Forty Seven, Inc., and Magenta Therapeutics, Inc. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Cambridge, Massachusetts.

Stock Peers

REGN

-24.1-3.05%

Regeneron Pharmaceuticals, Inc.$766.66 ARGX

-8.04-1.06%

argenx SE$748.72 UTHR

-15.17-2.95%

United Therapeutics Corporation$498.65 VRTX

-11.76-2.42%

Vertex Pharmaceuticals Incorporated$474.27 MDGL

-9.77-2.24%

Madrigal Pharmaceuticals, Inc.$425.85 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

-6.42-1.97%

Alnylam Pharmaceuticals, Inc.$318.65 PRAX

-12.37-3.74%

Praxis Precision Medicines, Inc.$318.22 KRYS

4.99+1.93%

Krystal Biotech, Inc.$263.80 ASND

-2.87-1.19%

Ascendis Pharma A/S$239.22

Frequently Asked Questions

What is the current bluebird bio, Inc. (BLUE) stock price?

bluebird bio, Inc. (NASDAQ: BLUE) stock price is $4.97 in the last trading session. During the trading session, BLUE stock reached the peak price of $4.97 while $4.97 was the lowest point it dropped to. The percentage change in BLUE stock occurred in the recent session was 0% while the dollar amount for the price change in BLUE stock was $0.00.

BLUE's industry and sector of operation?

The NASDAQ listed BLUE is part of Biotechnology industry that operates in the broader Healthcare sector. bluebird bio, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of BLUE?

Sarah Alspach
Chief Communications Officer
Dr. Liviu Niculescu M.D., Ph.D.
Senior Vice President of Global Medical Affairs
Mr. Richard Colvin M.D., Ph.D.
Chief Medical Officer
Mr. Christopher Krawtschuk CPA
Chief Financial Officer, Principal Accounting Officer & Treasurer
Mr. Thomas J. Klima
Chief Commercial Officer & Chief Operating Officer
Ms. Elizabeth Pingpank
Director of Corporation Communications
Mr. Scott Shoemaker
Senior Vice President of Quality
Ms. Melissa Bonner
Senior Vice President of Research
Jess Rowlands
Head of Corporation Communications
Mr. Christopher Krawtschuk C.P.A.
Chief Financial Officer, Principal Accounting Officer & Treasurer
Ms. Andrea Walton
Chief People Officer
Mr. Andrew Obenshain
Pres, Chief Executive Officer & Director
Mr. Richard A. Colvin M.D., Ph.D.
Chief Medical Officer
Mr. Kasra Kasraian
Senior Vice President of Technical Devel. & Operations
Mr. Joseph D. Vittiglio Esq., J.D.
Chief Bus. & Legal Officer and Corporation Sec.

How BLUE did perform over past 52-week?

BLUE's closing price is 55.31% higher than its 52-week low of $3.20 where as its distance from 52-week high of $28.60 is -82.62%.

How many employees does BLUE have?

Number of BLUE employees currently stands at 248.

Link for BLUE official website?

Official Website of BLUE is: https://www.bluebirdbio.com

How do I contact BLUE?

BLUE could be contacted at phone 339 499 9300 and can also be accessed through its website. BLUE operates from 60 Binney Street, Cambridge, MA 02142, United States.

How many shares of BLUE are traded daily?

BLUE stock volume for the day was 1.25M shares. The average number of BLUE shares traded daily for last 3 months was 576.32K.

What is the market cap of BLUE currently?

The market value of BLUE currently stands at $48.67M with its latest stock price at $4.97 and 9.79M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	248
Beta	0.36
Sales or Revenue	$3.60M
5Y Sales Change%	-0.744%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	248
Beta	0.36
Sales or Revenue	$3.60M
5Y Sales Change%	-0.744%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

BLUE Company Profile and Key Details

bluebird bio

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Company Overview

Price Forecast & Outlook

Key Takeaways

Valuation Metrics